scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0022-3476(86)81059-9 |
P698 | PubMed publication ID | 3701523 |
P2093 | author name string | Andrew M | |
Johnston M | |||
Carter C | |||
Giron D | |||
Kelton J | |||
Castle V | |||
P2860 | cites work | Autoimmune Platelet Destruction: Idiopathic Thrombocytopenic Purpura | Q33476311 |
Platelet kinetics with indium-111 platelets: comparison with chromium-51 platelets | Q33477315 | ||
Discriminant study of platelet volume indices in the etiological diagnosis of thrombocytopenia | Q33478138 | ||
The measurement of platelet-associated IgG using an immunoradiometric assay | Q33479802 | ||
Differential diagnosis of various thrombocytopenias in childhood by analysis of platelet volume | Q33482798 | ||
Immune thrombocytopenia in severe neonatal infections | Q33484057 | ||
Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations | Q33486684 | ||
Thrombocytopenia in the high-risk infant | Q33487166 | ||
Coagulation Studies in Severe Birth Asphyxia | Q39496344 | ||
The megathrombocyte as an index of platelet production | Q39874707 | ||
Methodologic and basic aspects of indium-111 platelets | Q40207865 | ||
Neonatal thrombocytopenia | Q70367756 | ||
A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants | Q70455780 | ||
Coagulation Defects in Hypoxic Full-term Newborn Infants | Q70620225 | ||
Factor II (prothrombin) levels in cord blood: correlation of coagulant activity with immunoreactive protein | Q71404568 | ||
Clinical assessment of gestational age in the newborn infant | Q71466810 | ||
Acquired haemostatic defects in the ill newborn | Q71727034 | ||
Platelet-associated IgG is a specific protein | Q93568422 | ||
Electroimmuno assay | Q93725185 | ||
P433 | issue | 5 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thrombocytopenia | Q585285 |
P304 | page(s) | 749-755 | |
P577 | publication date | 1986-05-01 | |
P1433 | published in | The Journal of Pediatrics | Q7743611 |
P1476 | title | Frequency and mechanism of neonatal thrombocytopenia | |
P478 | volume | 108 |
Q33330800 | A bone marrow biopsy technique suitable for use in neonates |
Q33493763 | A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants |
Q33376796 | A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia |
Q33382669 | An approach to the management of infants with impaired haemostasis |
Q30469247 | Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens |
Q35064114 | Approach to the bleeding child |
Q33489648 | Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia |
Q33379900 | Association of Neonatal Thrombocytopenia and Maternal Anti-HLA Antibodies |
Q33420803 | Biomarkers of multiorgan injury in neonatal encephalopathy |
Q33422269 | Bleeding issues in neonates and infants - update 2015. |
Q53472873 | Blood and blood component therapy in neonates. |
Q33496834 | Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates |
Q33457027 | Clinical impact of neonatal thrombocytopenia |
Q33356603 | Coagulation screening tests in high risk neonates: a prospective cohort study |
Q34894565 | Coagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia: a retrospective case-control study |
Q33441520 | Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities |
Q33442148 | Developmental differences between newborn and adult mice in response to romiplostim |
Q33388137 | Differences between newborn and adult mice in their response to immune thrombocytopenia |
Q33333937 | Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin |
Q33415608 | Early-onset thrombocytopenia in near-term and term infants with perinatal asphyxia. |
Q37710993 | Effect of temperature on thromboelastography and implications for clinical use in newborns undergoing therapeutic hypothermia |
Q33358017 | Effects of anoxia on megakaryocyte progenitors derived from cord blood CD34pos cells |
Q33394140 | Effects of in vitro adult platelet transfusions on neonatal hemostasis |
Q33348599 | Effects of oxygen-induced lung damage on megakaryocytopoiesis and platelet homeostasis in a rat model |
Q33379984 | Effects of sepsis on neonatal thrombopoiesis |
Q33501384 | Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies |
Q33417661 | Evaluation and management of thrombocytopenic neonates in the intensive care unit |
Q33334104 | Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit |
Q33413694 | Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan |
Q33392634 | Fetal and neonatal thrombocytopenia |
Q71791726 | Fetal and neonatal thrombocytopenia |
Q33340332 | Fetomaternal alloimmune thrombocytopenia |
Q33334273 | Gestational thrombocytopenia and immune thrombocytopenias in pregnancy |
Q33397361 | How I manage neonatal thrombocytopenia |
Q33378272 | How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity |
Q33410265 | Hypoxia as a predisposing factor for the development of early onset neonatal thrombocytopenia |
Q33338497 | Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy |
Q33348204 | Inter-NICU variation in rates and management of thrombocytopenia among very low birth-weight infants |
Q28200791 | Interleukin-11 levels in healthy and thrombocytopenic neonates |
Q33395092 | Is a small platelet mass associated with intraventricular hemorrhage in very low-birth-weight infants? |
Q33406151 | Low immature platelet fraction suggests decreased megakaryopoiesis in neonates with sepsis or necrotizing enterocolitis |
Q33395211 | Maternal preeclampsia and neonatal outcomes |
Q33375326 | Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates |
Q33392339 | NCI classification of thrombocytopenia in extremely preterm neonates and its association with mortality and morbidity |
Q33366034 | Neonatal Gaucher disease presenting as persistent thrombocytopenia |
Q33433849 | Neonatal Immune Thrombocytopenia |
Q33430391 | Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia |
Q38390294 | Neonatal haemostasis |
Q33390642 | Neonatal thrombocytopenia and megakaryocytopoiesis |
Q33403380 | Neonatal thrombocytopenia and platelets transfusion |
Q64991458 | Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood. |
Q24673677 | Neonatal thrombocytopenia: causes and management |
Q33502066 | Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay |
Q35556499 | Neonatal transfusion practice |
Q33402060 | New insights into thrombopoiesis in neonatal sepsis |
Q37339107 | Newborn illnesses caused by transplacental antibodies |
Q33388036 | Nosocomial sepsis-induced late onset thrombocytopenia in a neonatal tertiary care unit: a prospective study |
Q63916614 | Ontogeny of platelet function |
Q52961931 | Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. |
Q33706432 | Perinatal asphyxia in less developed countries |
Q33333554 | Perinatal thrombocytopenia of maternal origin |
Q33331487 | Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys |
Q33432436 | Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants. |
Q27013796 | Platelet Transfusions in the Neonatal Intensive Care Unit |
Q33403314 | Platelet count and serum thrombopoietin level as predictors for morbidity and/or mortality in thrombocytopenic neonates |
Q46872070 | Platelet counts in maternal and umbilical venous blood at the time of delivery |
Q33499533 | Platelet disorders in newborn infants: diagnosis and management |
Q39202811 | Platelet function testing in pediatric patients |
Q33424354 | Platelet mass index: is it a hope for reduction of platelet transfusion in NICU? |
Q33342076 | Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients |
Q33488344 | Platelet transfusion therapy in newborn infants |
Q33395699 | Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland |
Q33489531 | Platelet transfusions in neonatology |
Q47622222 | Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions |
Q33736979 | Postasphyxial management of the newborn. |
Q33425531 | Prognostic significance of early platelet count decline in preterm newborns |
Q33454755 | Reduction of platelet counts induced by mechanical ventilation in newborn infants |
Q34984870 | Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment |
Q33496654 | Reticulated platelet values in normal and thrombocytopenic neonates |
Q36978114 | Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants |
Q33387879 | Significance of immature platelet fraction and CD41-positive cells at birth in early onset neonatal thrombocytopenia |
Q33454099 | Subcapsular hematoma of the liver in infants of very low birth weight. |
Q31038266 | Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system |
Q33495138 | Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients |
Q33406581 | Thrombocytopenia in neonates: causes and outcomes |
Q71124262 | Thrombocytopenia in the neonate |
Q33374735 | Thrombocytopenia related neonatal outcome in preterms |
Q74628956 | Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development |
Q33331485 | Thrombopoietin and neonatal thrombocytopenia |
Q33329430 | Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. |
Q33333802 | Thrombopoietin in the fetus and neonate |
Q50325363 | Transcapillary fluid flux and inflammatory response during neonatal therapeutic hypothermia: an open, longitudinal, observational study |
Q33411431 | Transfusing neonates based on platelet count vs. platelet mass: a randomized feasibility-pilot study |
Q33433380 | Wiskott-Aldrich Syndrome Presenting with JMML-Like Blood Picture and Normal Sized Platelets |
Search more.